PERTUZUMAB BETA
UNII C2K4EYY5HY

Substance Identification & Data

This profile provides standardized clinical and technical data for Pertuzumab Beta, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C2K4EYY5HY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2785394-06-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C2K4EYY5HY

CAS Registry Number

2785394-06-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PERTUZUMAB BETA

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14025

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pertuzumab Beta. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PERTUZUMAB BETA

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL BAT1006 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BAT1006 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY (PERTUZUMAB BETA)

PERTUZUMAB BETA [INN]

External Clinical & Regulatory Resources

Previous UNIIC2K325S808

Next UNIIC2K4P9N82X